Which option indicates the 2012 Medical Device User Fees Amendment aims to improve the overall review process?

Which option indicates the 2012 Medical Device User Fees Amendment aims to improve the overall review process?

• A. It authorizes user fees for post-market surveillance
• B. It limits the number of pre-market submissions
• C. It authorizes the FDA to collect user fees for pre-market approvals to improve the overall review process
• D. It eliminates user fees entirely

Answer: (C)

The question is about how the Medical Device User Fees Amendment is designed to support FDA’s review work. The key idea is that charging user fees for pre-market approvals provides dedicated resources to fund the review process, which helps speed up and improve the quality and consistency of decisions. By supplying funds specifically for pre-market submissions (such as PMAs and certain 510(k) reviews), the amendment aims to enhance reviewer capacity, streamline timelines, and offer more predictability for sponsors, all while maintaining safety standards. The other statements don’t reflect this mechanism: fees tied to post-market activities, limiting submissions, or eliminating fees do not align with the goal of strengthening pre-market review efficiency and transparency.

The question is about how the Medical Device User Fees Amendment is designed to support FDA’s review work. The key idea is that charging user fees for pre-market approvals provides dedicated resources to fund the review process, which helps speed up and improve the quality and consistency of decisions. By supplying funds specifically for pre-market submissions (such as PMAs and certain 510(k) reviews), the amendment aims to enhance reviewer capacity, streamline timelines, and offer more predictability for sponsors, all while maintaining safety standards. The other statements don’t reflect this mechanism: fees tied to post-market activities, limiting submissions, or eliminating fees do not align with the goal of strengthening pre-market review efficiency and transparency.